| 2012 | | Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus | 김기범, 김순선, 정재연, 조성원, 조진희 |
| 2006 | | Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. | 김진홍, 정재연, 조성원, 함기백 |
| 2014 | | Association of a microRNA-323b polymorphism with the persistence of hepatitis B virus infection by the enhancement of viral replication | 정재연, 조성원 |
| 2013 | | Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection. | 정재연, 조성원 |
| 2014 | | Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma. | 정재연, 조성원 |
| 2012 | | Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients | 정재연, 조성원 |
| 2012 | | Changes in serum histologic surrogate markers and procollagen III N-terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy | 김순선, 김진홍, 유병무, 이광재, 이기명, 이명희, 정재연, 조성원 |
| 2011 | | Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B. | 조성원 |
| 2011 | | Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B. | 김순선, 이명희, 정재연, 조성원 |
| 2012 | | Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis | 정재연, 조성원 |
| 2013 | | Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B. | 정재연 |
| 2002 | | Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion. | 김진홍, 이기명, 조성원, 함기백 |
| 1994 | | Efficacy of polyadenylic.polyuridylic acid in the treatment of chronic active hepatitis B. | 윤정구, 함기백 |
| 2012 | | Entecavir Therapy for Patients with Hepatitis B Virus-related Decompensated Cirrhosis | 정재연, 조성원 |
| 2016 | | Evaluation of the Effectiveness of NK Vue Gold Kit in Patients with Chronic Hepatitis B | 김순선, 임영애, 정재연, 조성원 |
| 2016 | | Genetic polymorphisms in the Wnt/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 노충균, 신성재, 유병무, 이광재, 이기명, 정재연, 조성원, 조효정 |
| 2015 | | High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation. | 김봉완, 김순선, 김재근, 노충균, 신성재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2002 | | HLA-A2 1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo. | 김형일 |
| 2017 | | Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population | 조성원 |
| 2014 | | Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 신성재, 안선주, 유병무, 이기명, 정재연, 조성원, 조효정 |
| 2015 | | Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. | 강대용, 김순선, 김재근, 박주한, 신성재, 원제환, 유병무, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2005 | | Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population. | 김진홍, 정재연, 조성원, 함기백 |
| 2010 | | Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance. | 고경현, 이명희, 정재연, 조성원 |
| 2015 | | Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. | 김순선, 김재근, 박주한, 왕희정, 정재연, 조성원, 조효정 |
| 2013 | | Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy. | 김순선, 정재연, 조성원 |
| 2013 | | Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence. | 정재연, 조성원 |
| 2007 | | RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. | 김진홍, 정재연, 조성원 |
| 2023 | | Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection | 김순선 |
| 2000 | | Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy. | 김진홍, 조성원, 함기백 |
| 2021 | | Role of immune cells in patients with hepatitis b virus‐related hepatocellular carcinoma | 정재연, 조효정 |
